According to a new study in Haemophilia, up to 60% of patients with severe HA have no known family history, making early ...

These tools, available through the myCigna member portal, are designed to make navigating health insurance more ...

Ibtrozi had a 90% response rate in treatment naïve adults with locally advanced or metastatic ROS1-positive non-small cell ...

The company's CEO points to using a subscription-based model, being a platform that allows for technology integration and scale and transparency.

Findings mark the first time a neoadjuvant immunotherapy regimen has demonstrated a significant survival benefit in a ...

A cloud-based digital twin simulation, coupled with automated insulin delivery, allows patients with diabetes to experiment ...

EGFR inhibitors such as Erbitux and Gilotrif show potential in laboratory and mouse studies in treating melanoma with a ...

The booking feature is now live for all Blue Shield employer-sponsored plans, Individual and Family Plans and Medicare ...

Although some HIV programs will remain, the proposed cuts in the fiscal year 2026 budget are too severe and will hinder HIV ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

A survey by PSG has found that the pressure to control drug costs is leading some payers to look into unbundling pharmacy ...

Researchers found that altering key enzymes involved in redox balance could disrupt the metabolism of Myc-driven lymphomas, ...